Results

Total Results: 475 records

Showing results for "gender".

1. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
   December 26, 2022 - served by the rural telehealth programs: the age of the participants, their race, their ethnicity, and gender … Was it is conscious decision to exclude sexual orientation and gender identity. … We did not restrict inclusion of studies by sexual orientation, gender identify, or any other … Was it is conscious decision to exclude sexual orientation and gender identity. … We did not restrict inclusion of studies by sexual orientation, gender identify, or any other

2. Management of Acute Diverticulitis Additional Information for Topic Nomination (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-nomination-extra.pdf
   May 29, 2025 - Prevention of recurrence Population Adults with diverticulitis Subgroups: age, ethnicity, gender … comorbidities, disease presentation Adults with diverticulitis Subgroups: age, ethnicity, gender … comorbidities, disease presentation Adults with suspected diverticulitis Subgroups: age, ethnicity, gender … comorbidities, disease presentation Adults with resolved episode of ACD Subgroups: age, ethnicity, gender … Adults with recurrent diverticulitis (complicated or uncomplicated) Subgroups: age, ethnicity, gender

3. Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement.pdf
   February 05, 2025 - interventions for high-risk groups such as youth of different sexes, sexual orientations, and gender … To be compliant with the Executive Order 14168 “Defending Women from Gender Ideology Extremism and … /gender identity sex To be compliant with the Executive Order 14168 “Defending Women from Gender … Ideology Extremism and Restoring Biological Truth to the Federal Government” mention of gender/gender … identity as specific subgroups has been removed 2/5/2025 Table 1, PICOTS, subgroup analysis

4. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.xlsx
   January 01, 2011 - of Diabetes in Medicare Parts A and B FFS Cohort Population (Millions), 2006-2008 By Age Category, Gender … 75 to 84 2006 10.2 2.8 28.0% 85 to 94 2006 4.0 1.0 24.1% 95 and older 2006 0.4 0.1 16.7% Gender … 75 to 84 2007 9.8 2.9 29.0% 85 to 94 2007 4.1 1.0 25.1% 95 and older 2007 0.4 0.1 17.5% Gender … 75 to 84 2008 9.4 2.8 29.8% 85 to 94 2008 4.1 1.1 25.9% 95 and older 2008 0.4 0.1 18.1% Gender … of Foot Ulcer Among Diabetic Medicare Parts A and B FFS Beneficiaries, 2006-2008 By Age Category, Gender

5. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.xlsx
   January 01, 2011 - Ulcer Among Diabetic Medicare Parts A and B Fee-for-Service Beneficiaries, 2006-2008 By Age Category, Gender … to 84 2006 6.2% 12.8% 4.0% 85 to 94 2006 8.8% 15.0% 5.8% 95 and older 2006 11.5% 17.1% 8.1% Gender … to 84 2007 6.1% 12.5% 3.9% 85 to 94 2007 8.7% 14.8% 5.8% 95 and older 2007 11.4% 16.7% 8.0% Gender … to 84 2008 6.0% 12.2% 3.9% 85 to 94 2008 8.7% 14.6% 5.7% 95 and older 2008 11.3% 16.4% 7.9% Gender … Among Diabetic Medicare Parts A and B Fee-for-Service Beneficiaries, 2006 - 2008 By Age Category, Gender

6. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
   January 01, 2011 - Diabetes in Medicare Parts A and B Fee-for-Service (FFS) Cohort Population (Millions), 2006-2008, by Age, Gender … 26.4% 75 to 84 2006 10.2 2.8 28.0% 85 to 94 2006 4.0 1.0 24.1% 95 and over 2006 0.4 0.1 16.7% Gender … 27.2% 75 to 84 2007 9.8 2.9 29.0% 85 to 94 2007 4.1 1.0 25.1% 95 and over 2007 0.4 0.1 17.5% Gender … 27.7% 75 to 84 2008 9.4 2.8 29.8% 85 to 94 2008 4.1 1.1 25.9% 95 and over 2008 0.4 0.1 18.1% Gender … to 84 2006 8.0% 17.7% 4.9% 85 to 94 2006 11.5% 20.4% 7.3% 95 and over 2006 15.3% 23.0% 10.6% Gender

7. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
   January 01, 2011 - Ulcer Among Diabetic Medicare Parts A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender … 75 to 84 2006 6.2% 12.8% 4.0% 85 to 94 2006 8.8% 15.0% 5.8% 95 and over 2006 11.5% 17.1% 8.1% Gender … 75 to 84 2007 6.1% 12.5% 3.9% 85 to 94 2007 8.7% 14.8% 5.8% 95 and over 2007 11.4% 16.7% 8.0% Gender … 75 to 84 2008 6.0% 12.2% 3.9% 85 to 94 2008 8.7% 14.6% 5.7% 95 and over 2008 11.3% 16.4% 7.9% Gender … LEA) Among Diabetic Medicare Parts A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender

8. Data-Points-7-Tables1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.xls
   May 29, 2025 - ASPARAGINASE 95 and over - - - - - - - - - Miscellaneous Biologic Nonblood Products ASPARAGINASE Gender … - 1.0% - Kinase Inhibitors DASATINIB 95 and over - - - - - - - - - Kinase Inhibitors DASATINIB Gender … Modifiers DENILEUKIN 95 and over 0.3% - - 0.2% - - - - - Biologic Response Modifiers DENILEUKIN Gender … - - - Kinase Inhibitors EVEROLIMUS 95 and over - - - - - - - - - Kinase Inhibitors EVEROLIMUS Gender … - - - - Kinase Inhibitors GEFITINIB 95 and over - - - - - - - - - Kinase Inhibitors GEFITINIB Gender

9. Data-Points-7-Tables (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.xls
   May 29, 2025 - ASPARAGINASE 95 and over - - - - - - - - - Miscellaneous Biologic Nonblood Products ASPARAGINASE Gender … - 1.0% - Kinase Inhibitors DASATINIB 95 and over - - - - - - - - - Kinase Inhibitors DASATINIB Gender … Modifiers DENILEUKIN 95 and over 0.3% - - 0.2% - - - - - Biologic Response Modifiers DENILEUKIN Gender … - - - Kinase Inhibitors EVEROLIMUS 95 and over - - - - - - - - - Kinase Inhibitors EVEROLIMUS Gender … - - - - Kinase Inhibitors GEFITINIB 95 and over - - - - - - - - - Kinase Inhibitors GEFITINIB Gender

10. Data-Points-7-Tables1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
    May 29, 2025 - Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, Age, Gender … antibodies Alemtuzumab 85 to 94 * 1.4 0.7 5.2 1.1 * * 1.5 1.2 Monoclonal antibodies Alemtuzumab Gender … antibodies Cetuximab 95 and over * 0.1 * 0.2 0.2 * 0.1 0.1 0.0 Monoclonal antibodies Cetuximab Gender … Kinase inhibitors Dasatinib 85 to 94 * 1.4 5.5 3.2 1.0 * * 1.0 * Kinase inhibitors Dasatinib Gender … 0.9 Kinase inhibitors Imatinib 95 and over * * 0.4 0.2 0.2 * * * * Kinase inhibitors Imatinib Gender

11. Data-Points-7-Tables (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
    May 29, 2025 - Continuous AB FFS Enrollment Prior to First Relevant Claim by Class of Drug, Active Ingredient, Age, Gender … antibodies Alemtuzumab 85 to 94 * 1.4 0.7 5.2 1.1 * * 1.5 1.2 Monoclonal antibodies Alemtuzumab Gender … antibodies Cetuximab 95 and over * 0.1 * 0.2 0.2 * 0.1 0.1 0.0 Monoclonal antibodies Cetuximab Gender … Kinase inhibitors Dasatinib 85 to 94 * 1.4 5.5 3.2 1.0 * * 1.0 * Kinase inhibitors Dasatinib Gender … 0.9 Kinase inhibitors Imatinib 95 and over * * 0.4 0.2 0.2 * * * * Kinase inhibitors Imatinib Gender

12. Medical Care for Adults with Down Syndrome (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - Sex To be compliant with the Executive Order 14168 “Defending Women from Gender Ideology … of gender been removed in relation to patient characteristics. … of gender been removed in relation to patient characteristics. … of gender been removed in relation to patient characteristics. … Instead we have included T sex as a more precise term rather than gender VIII.

13. Data-Points-6-Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
    January 01, 2006 - Response Modifiers ALDESLEUKIN Gender Female 0.06 0.03 0.03 0.03 0.033 0.019 0.017 0.015 Biologic … Male 16.30 16.42 16.43 16.80 7.096 7.172 7.199 7.379 Biologic Response Modifiers BCG Gender Female … Kinase Inhibitors EVEROLIMUS Gender Male . . . 0.18 . . . 0.080 Kinase Inhibitors EVEROLIMUS Gender … Kinase Inhibitors LAPATINIB Gender Male . . 0.01 0.01 . . 0.004 0.004 Kinase Inhibitors LAPATINIB Gender … Kinase Inhibitors PAZOPANIB Gender Male . . . 0.01 . . . 0.006 Kinase Inhibitors PAZOPANIB Gender Female

14. Hypertension-Drugs-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
    January 25, 2011 - The annual prevalence of hypertension differed with regard to demographic fac- tors, such as age, gender … 2009 89.2 2.0 ± 1.3 85 and over 2007 89.4 2.0 ± 1.2 2008 89.7 2.0 ± 1.2 2009 89.6 2.0 ± 1.3 Gender … Percentages of antihypertensive drug use among beneficiaries with hypertension varied by age, gender … Gender, race/ethnicity, and age were all extracted from the EDB. … and Use of One or More Antihypertensive Drugs, by Drug Class and HRR; Adjusted by Age Category, Gender

15. Data-Points-6-Tables1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
    January 01, 2009 - Male 0.16 0.10 0.10 0.07 0.068 0.044 0.042 0.031 Biologic response modifiers Aldesleukin Gender … Male 1.62 0.08 0.05 0.06 0.707 0.034 0.023 0.026 Biologic response modifiers Denileukin Gender … Male 0.07 0.16 0.19 0.22 0.030 0.070 0.084 0.098 Kinase inhibitors Dasatinib Gender Female 0.10 0.20 … Male 1.62 1.78 1.93 2.12 0.706 0.779 0.847 0.930 Kinase inhibitors Imatinib Gender Female 1.52 1.63 … Male * * 0.29 1.05 * * 0.127 0.462 Kinase inhibitors Temsirolimus Gender Female * * 0.10 0.44 * *

16. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-protocol-amendment.pdf
    February 05, 2025 - identity, and sexual orientation, sex, To be compliant with the Executive Order 14168 “Defending … of gender identities or sexual orientation groups as specific high risk groups has been removed … 2/5/2025 Table 1, PICOTS gender/sex identity, sexual orientation, sex, To be compliant with the … Executive Order 14168 “Defending Women from Gender Ideology Extremism and Restoring Biological Truth … to the Federal Government” mention of gender identities or sexual orientation groups as specific

17. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0265_02-29-2008.pdf
    January 01, 2008 - How to explain gender disparities in response to pain treatment (psych, estrogen, etc.)? 7. … Are there disparities other than gender (socioeconomic status, ethnicity, geography)? 8. … nonpharmacologic pain management interventions vary in differing subpopulations including but not limited to: gender

18. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol-amendment.pdf
    February 03, 2025 - Breastfeeding includes feeding at the breast (direct breastfeeding) Gender neutral term of “lactating … 17 Breastfeeding and Infant and Child Health Outcomes Final Protocol Transgender men and gender … As such, the word “breastfeeding” itself may be less accurate for gender-diverse parents, who … As studies report on populations and infant feeding in more gender- inclusive language, we will … identity: a qualitative study.

19. Topic 0318 Psychiatric Hospital Discharge NSD FINAL (2)_SJ_Clean-2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
    November 06, 2013 - diagnosis (e.g., psychotic or mood disorders), demographics (e.g., elderly, homelessness, race/ethnicity, gender … (e.g., psychotic or mood disorders), o demographics (e.g., elderly, homelessness, race/ethnicity, gender … (e.g., psychotic or mood disorders), o demographics (e.g., elderly, homelessness, race/ethnicity, gender

20. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - These rates have been shown to exhibit variation by age, gender, race/ethnicity, and Dartmouth Atlas … Foot ulcer rates varied by age, gender, race/ ethnicity, and geographic location. … Incidence varied by age, gender, race/eth- nicity, and geographic location. … , race/ethnicity ** age, gender, race/ethnicity, obesity, microvascular conditions, macrovascular … Gender, race/ethnicity, and age were all extracted from the EDB.